ADVERSE PREGNANCY OUTCOMES IN OLIGOHYDRAMNIOS MEASURE BY AMNIOTIC FLUID

Main Article Content

Dr. Khansa Fazil Qazi
Dr. Sabaeena Wali
Dr. Lailma Tariq
Dr. Amna Begum
Naeema Bibi
Dr. Mujeeb Ur Rehman Sahito

Keywords

Adverse pregnancy events, oligohydramnios

Abstract

Background:  Pregnancy is the time period between conception and delivery of the baby. Normal period ranges from 37 weeks to 42 weeks. Adverse pregnancy outcome includes adverse event, more especially, to infant like infant mortality/morbidity, stillbirth and low birth weight.  


Objective:  To determine the frequencies of adverse pregnancy events in oligohydramnios patients in pregnant women


Material and Methods: This descriptive study was carried out in the Department of Gynecology, Lady Reading Hospital, Peshawar in collaboration with technical help of Karachi Metropolitan University for six months from 15th August 2020 to 15th February 2021. In the present study all patient coming for antenatal assessment having Oligohydramnios in age 18 to 40 years, single gestation, parity = 0 to 5, gravida= 1 to 5, gestational age= third trimester were included, each patient was send for assessment of Oligohydramnios by AFI. In all patient’s demographic data was taken. Ultrasound was done for AFI by an experienced radiologist of at least 3-year post-graduation training. The data was noted in the questionnaire. At the time of delivery or any other emergency the parameter of adverse pregnancy outcomes (mentioned in operational definition) was assessed and was noted in the proforma. The patients were discussed with senior if any treatment is possible the treatment if given any was also noted in proforma.


Results: Our study shows that among 123 patients mean age was 31 years with standard deviation± 9.91. Mean POG was 38 weeks with standard deviation± 4.12. 73(59%) women had adverse pregnancy outcomes in which 22(30%) women had delivery by cesarean section, 11(15%) women had fetal distress, 6(8%) women had still birth, 8(11%) women had meconium in amniotic fluid, 13(18%) neonates were admitted to neonatal ICU, 13(18%) neonates had Apgar score <7 at 5 mint.  


Conclusion:  Our study concludes that frequencies of adverse pregnancy events was 59% in which delivery by cesarean section was 30%, fetal distress was 15%, still birth was 8%, meconium in amniotic fluid was 11%, admission to neonatal ICU was 18% and Apgar score <7 at 5 was 18% in patients presenting with oligohydramnios 

Abstract 124 | PDF Downloads 26

References

1. Cousens S, Blencowe H, Stanton C, Chou D, Ahmed S, Steinhardt L, et al. National, regional, and worldwide estimates of stillbirth rates in 2009 with trends since 1995: a systematic analysis. Lancet. 2011 Apr;377(9774):1319–30.
2. Pasha O, Saleem S, Ali S, Goudar SS, Garces A, Esamai F, et al. Maternal and newborn outcomes in Pakistan compared to other low and middle income countries in the Global Network’s Maternal Newborn Health Registry: an active, community-based, pregnancy surveillance mechanism. Reprod Health. 2015 Dec 8;12(S2):S15.
3. Kramer MS. The Epidemiology of Adverse Pregnancy Outcomes: An Overview. J Nutr. 2003 May;133(5):1592S-1596S.
4. Vogel JP, Pileggi-Castro C, Chandra-Mouli V, Pileggi VN, Souza JP, Chou D, et al. Millennium Development Goal 5 and adolescents: looking back, moving forward. Arch Dis Child. 2015 Feb;100(Suppl 1):S43–7.
5. Warren JL, Perez-Heydrich C, Burgert CR, Emch ME. Influence of Demographic and Health Survey Point Displacements on Distance-Based Analyses. Spat Demogr. 2016 Jul 23;4(2):155–73.
6. Meherali S, Ali A, Khaliq A, Lassi ZS. Prevalence and determinants of contraception use in Pakistan: trend analysis from the Pakistan Demographic and Health Surveys (PDHS) dataset from 1990 to 2018. F1000Research. 2021 Aug 11;10:790.
7. Bhutta ZA, Hafeez A, Rizvi A, Ali N, Khan A, Ahmad F, et al. Reproductive, maternal, newborn, and child health in Pakistan: challenges and opportunities. Lancet. 2013 Jun;381(9884):2207–18.
8. Morris R, Meller C, Tamblyn J, Malin G, Riley R, Kilby M, et al. Association and prediction of amniotic fluid measurements for adverse pregnancy outcome: systematic review and meta‐analysis. BJOG An Int J Obstet Gynaecol. 2014 May 7;121(6):686–99.
9. Locatelli A, Vergani P, Toso L, Verderio M, Pezzullo JC, Ghidini A. Perinatal outcome associated with oligohydramnios in uncomplicated term pregnancies. Arch Gynecol Obstet. 2004 Jan 20;269(2):130–3.
10. Chauhan SP, Sanderson M, Hendrix NW, Magann EF, Devoe LD. Perinatal outcome and amniotic fluid index in the antepartum and intrapartum periods: A meta-analysis. Am J Obstet Gynecol. 1999 Dec;181(6):1473–8.
11. Nath J, Jain M, Najam R. A CLINICAL STUDY ON OLIGOHYDRAMNIOS IN THE THIRD TRIMESTER OF PREGNANCY WITH SPECIAL EMPHASIS ON THE PERINATAL OUTCOME. J Evol Med Dent Sci. 2013 Sep 24;2(39):7386–91.
12. Talesara H, Shah VCC, Modi DA, Modi RS. Fetomaternal outcome in pregnancy with oligohydramnios: a prospective study. Int J Reprod Contraception, Obstet Gynecol. 2021 Jan 28;10(2):571.
13. Bachhav AA, Waikar M. Low Amniotic Fluid Index at Term as a Predictor of Adverse Perinatal Outcome. J Obstet Gynecol India. 2014 Apr 18;64(2):120–3.
14. Casey BM, McIntire DD, Bloom SL, Lucas MJ, Santos R, Twickler DM, et al. Pregnancy outcomes after antepartum diagnosis of oligohydramnios at or beyond 34 weeks’ gestation. Am J Obstet Gynecol. 2000 Apr;182(4):909–12.
15. Zhang J, Troendle J, Meikle S, Klebanoff MA, Rayburn WF. Isolated oligohydramnios is not associated with adverse perinatal outcomes. BJOG An Int J Obstet Gynaecol. 2004 Mar 11;111(3):220–5.
16. Bowen-Chatoor JS, Kulkarni SK. Amniotic fluid index in the management of the postdates pregnancy. West Indian Med J. 1995 Jun;44(2):64–6.
17. Ghosh R, Oza H, Padhiyar B. Maternal and fetal outcome in oligohydramnios: study from a tertiary care hospital, Ahmedabad, India. Int J Reprod Contraception, Obstet Gynecol. 2018 Feb 27;7(3):907.

Most read articles by the same author(s)